CITIGROUP INC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 150 filers reported holding KURA ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.5%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$898,840
+11.5%
98,557
+29.3%
0.00%0.0%
Q2 2023$806,196
-70.2%
76,200
-65.5%
0.00%
-50.0%
Q1 2023$2,702,683
+50.6%
220,988
+52.8%
0.00%
+100.0%
Q4 2022$1,794,374
-49.0%
144,591
-43.8%
0.00%
-66.7%
Q3 2022$3,517,000
+94.5%
257,458
+161.0%
0.00%
+200.0%
Q2 2022$1,808,000
+244.4%
98,636
+202.5%
0.00%
Q1 2022$525,000
-78.4%
32,604
-81.3%
0.00%
-100.0%
Q4 2021$2,435,000
-15.2%
173,934
+13.4%
0.00%
-50.0%
Q3 2021$2,873,000
-24.6%
153,383
-16.0%
0.00%0.0%
Q2 2021$3,809,000
-5.8%
182,668
+27.7%
0.00%
-33.3%
Q1 2021$4,044,000
+742.5%
143,054
+874.3%
0.00%
Q4 2020$480,000
+240.4%
14,683
+220.1%
0.00%
Q3 2020$141,000
-71.9%
4,587
-85.1%
0.00%
Q2 2020$502,000
+131.3%
30,799
+41.3%
0.00%
Q1 2020$217,000
+22.6%
21,798
+68.9%
0.00%
Q4 2019$177,000
-69.7%
12,905
-66.6%
0.00%
Q3 2019$585,000
-25.3%
38,586
-3.0%
0.00%
-100.0%
Q2 2019$783,000
+17.9%
39,773
-0.6%
0.00%0.0%
Q1 2019$664,000
-57.8%
39,998
-64.3%
0.00%
-50.0%
Q4 2018$1,572,000
+84.3%
111,977
+129.8%
0.00%
+100.0%
Q3 2018$853,000
+58.8%
48,736
+65.2%
0.00%
Q2 2018$537,000
+7.6%
29,507
+10.9%
0.00%
Q1 2018$499,000
+239.5%
26,614
+177.7%
0.00%
Q4 2017$147,000
+47.0%
9,585
+43.9%
0.00%
Q3 2017$100,000
+40.8%
6,660
-12.9%
0.00%
Q2 2017$71,000
+12.7%
7,645
+6.9%
0.00%
Q1 2017$63,000
+90.9%
7,150
+26.5%
0.00%
Q4 2016$33,000
-5.7%
5,6500.0%0.00%
Q3 2016$35,000
+150.0%
5,650
+5.6%
0.00%
Q2 2016$14,000
-12.5%
5,350
+35.4%
0.00%
Q1 2016$16,0003,9500.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$16,871,5179.37%
Prosight Management, LP 1,932,456$17,623,9995.58%
ACUTA CAPITAL PARTNERS, LLC 702,093$6,403,0884.29%
ALETHEA CAPITAL MANAGEMENT, LLC 350,445$3,196,0583.93%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,335,845$66,902,9063.62%
Affinity Asset Advisors, LLC 856,535$7,811,5992.20%
TCG Crossover Management, LLC 1,423,642$12,983,6151.91%
EcoR1 Capital, LLC 5,806,871$52,958,6641.79%
BVF INC/IL 6,730,983$61,386,5651.66%
DAFNA Capital Management LLC 550,784$5,023,1501.56%
View complete list of KURA ONCOLOGY INC shareholders